SEC Form 4 · accession 0001140361-18-030732
Opus Genetics, Inc. · IRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter C. Brandt
Director
Period of report
Jun 28, 2018
Accepted (ET)
Jun 29, 2018 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001228627
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.46 | Jun 28, 2018 | A | 39,742 | A | Jun 28, 2019 | Jun 28, 2028 | Common Stock | 39,742 | 39,742 | D |